^
BIOMARKER:
HER-2 positive
i
Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Entrez ID:
HER-2 positive
Gastric Cancer
pembrolizumab + trastuzumab
Sensitive
:
A1
FDA - 6d
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
pembrolizumab + trastuzumab
Sensitive
:
A1
FDA - 6d
HER-2 positive
Gastric Cancer
RC48
Sensitive
:
C3
Gastric Cancer - 1wk
HER-2 positive
Gastric Cancer
trastuzumab-IFN-β mutein
Sensitive
:
D
AACR 2021 - 4wk
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + tucatinib
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + pertuzumab
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
margetuximab
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
trastuzumab
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive
:
A1
HER-2 positive
Gastric Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
fam-trastuzumab deruxtecan-nxki
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
ado-trastuzumab emtansine
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
pertuzumab/trastuzumab/hyaluronidase-zzxf
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
Kanjinti (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
Herzuma (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
neratinib
Sensitive
:
A1
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
Gastric Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
Gastric Cancer
trastuzumab
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
TCHP
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
TCH
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + lapatinib
Sensitive
:
A2
HER-2 positive
GastroEsophageal Cancer
trastuzumab
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our